Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

May Measurement Month 2017: an analysis of blood pressure screening results in Austria-Europe.

Perl S, Zweiker D, Niederl E, Kolesnik E, Zweiker G, Kraler E, Stoff I, Haberfeld H, Dichtl W, Koppelstätter C, Lhotta K, Ederer H, Putz-Bankutti C, Beaney T, Xia X, Poulter NR, Weber T.

Eur Heart J Suppl. 2019 Apr;21(Suppl D):D17-D20. doi: 10.1093/eurheartj/suz053. Epub 2019 Apr 24.

2.

Successful pregnancy in a patient with pulmonary renal syndrome double-positive for anti-GBM antibodies and p-ANCA
.

Sprenger-Mähr H, Zitt E, Soleiman A, Lhotta K.

Clin Nephrol. 2019 Feb;91(2):101-106. doi: 10.5414/CN109584.

PMID:
30431431
3.

Alprostadil treatment of critical limb ischemia in hemodialysis patients : A retrospective single-center analysis.

Popp W, Knoll F, Sprenger-Mähr H, Zitt E, Lhotta K.

Wien Klin Wochenschr. 2019 May;131(9-10):209-215. doi: 10.1007/s00508-018-1407-z. Epub 2018 Nov 12.

PMID:
30421286
4.

A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.

Vychytil A, Herzog R, Probst P, Ribitsch W, Lhotta K, Machold-Fabrizii V, Wiesholzer M, Kaufmann M, Salmhofer H, Windpessl M, Rosenkranz AR, Oberbauer R, König F, Kratochwill K, Aufricht C.

Kidney Int. 2018 Dec;94(6):1227-1237. doi: 10.1016/j.kint.2018.08.031. Epub 2018 Oct 22.

5.

Floating kidneys associated with Eisenmenger syndrome.

Burger A, Schmid F, Berger A, Cejna M, Lhotta K.

Kidney Int. 2018 Nov;94(5):1029. doi: 10.1016/j.kint.2018.05.010. No abstract available.

PMID:
30348295
6.

Treatment of Concurrent Thrombotic Thrombocytopenic Purpura and Graves' Disease: A Report on Two Cases.

Lhotta K, Zitt E, Sprenger-Mähr H, Loacker L, Becherer A.

Case Rep Endocrinol. 2018 Aug 9;2018:5747969. doi: 10.1155/2018/5747969. eCollection 2018.

7.

Anti-Laminin-332-Schleimhautpemphigoid mit laryngealer Beteiligung - adjuvante Behandlung mit Immunadsorption und Rituximab.

Hügel R, Lang A, Lhotta K, Elsässer W, Gächter J, Messmer EM, Schmidt E.

J Dtsch Dermatol Ges. 2018 Jul;16(7):897-900. doi: 10.1111/ddg.13569_g. No abstract available.

PMID:
29989373
8.

Anti-laminin 332 mucous membrane pemphigoid with laryngeal involvement - adjuvant treatment with immunoadsorption and rituximab.

Hügel R, Lang A, Lhotta K, Elsässer W, Gächter J, Messmer EM, Schmidt E.

J Dtsch Dermatol Ges. 2018 Jul;16(7):897-900. doi: 10.1111/ddg.13569. Epub 2018 Jun 21. No abstract available.

PMID:
29927519
9.

Long-term risk for end-stage kidney disease and death in a large population-based cohort.

Zitt E, Pscheidt C, Concin H, Kramar R, Peter RS, Beyersmann J, Lhotta K, Nagel G.

Sci Rep. 2018 May 16;8(1):7729. doi: 10.1038/s41598-018-26087-z.

10.

Functional Characterization of the Disease-Associated N-Terminal Complement Factor H Mutation W198R.

Cserhalmi M, Uzonyi B, Merle NS, Csuka D, Meusburger E, Lhotta K, Prohászka Z, Józsi M.

Front Immunol. 2017 Dec 13;8:1800. doi: 10.3389/fimmu.2017.01800. eCollection 2017.

11.

An unusual case of acute kidney injury after colonoscopy.

Lhotta K, Zitt E.

Kidney Int. 2017 Apr;91(4):989. doi: 10.1016/j.kint.2016.11.020. No abstract available.

PMID:
28314582
12.

Management of secondary hyperparathyroidism: practice patterns and outcomes of cinacalcet treatment with or without active vitamin D in Austria and Switzerland - the observational TRANSIT Study.

Pronai W, Rosenkranz AR, Bock A, Klauser-Braun R, Jäger C, Pendl G, Hemetsberger M, Lhotta K.

Wien Klin Wochenschr. 2017 May;129(9-10):317-328. doi: 10.1007/s00508-016-1153-z. Epub 2017 Jan 13.

13.

Response to active hepatitis B vaccination and mortality in incident dialysis patients.

Zitt E, Hafner-Giessauf H, Wimmer B, Herr A, Horn S, Friedl C, Sprenger-Mähr H, Kramar R, Rosenkranz AR, Lhotta K.

Vaccine. 2017 Feb 1;35(5):814-820. doi: 10.1016/j.vaccine.2016.12.032. Epub 2016 Dec 31.

14.

Acute Kidney Injury Treated with Dialysis outside the Intensive Care Unit: A Retrospective Observational Single-Center Study.

Sprenger-Mähr H, Zitt E, Lhotta K.

PLoS One. 2016 Sep 27;11(9):e0163512. doi: 10.1371/journal.pone.0163512. eCollection 2016.

15.

Anthropometric and Metabolic Risk Factors for ESRD Are Disease-Specific: Results from a Large Population-Based Cohort Study in Austria.

Zitt E, Pscheidt C, Concin H, Kramar R, Lhotta K, Nagel G.

PLoS One. 2016 Aug 18;11(8):e0161376. doi: 10.1371/journal.pone.0161376. eCollection 2016.

16.

Successful Treatment of Focal Segmental Glomerulosclerosis after Kidney Transplantation with Plasma Exchange and Abatacept in a Patient with Juvenile Rheumatoid Arthritis.

Sprenger-Mähr H, Zitt E, Soleiman A, Lhotta K.

Case Rep Transplant. 2016;2016:7137584. doi: 10.1155/2016/7137584. Epub 2016 Mar 20.

17.

[Management of secondary hyperparathyroidism-current impact of parathyroidectomy].

Zitt E, Lhotta K.

Wien Med Wochenschr. 2016 May;166(7-8):254-8. doi: 10.1007/s10354-016-0444-3. Epub 2016 Feb 25. Review. German.

PMID:
26913524
18.

Autosomal dominant tubulointerstitial kidney disease caused by uromodulin mutations: seek and you will find.

Raffler G, Zitt E, Sprenger-Mähr H, Nagel M, Lhotta K.

Wien Klin Wochenschr. 2016 Apr;128(7-8):291-4. doi: 10.1007/s00508-015-0948-7. Epub 2016 Jan 25.

PMID:
26810206
19.

Sex- and Time-Dependent Patterns in Risk Factors of End-Stage Renal Disease: A Large Austrian Cohort with up to 20 Years of Follow-Up.

Pscheidt C, Nagel G, Zitt E, Kramar R, Concin H, Lhotta K.

PLoS One. 2015 Aug 31;10(8):e0135052. doi: 10.1371/journal.pone.0135052. eCollection 2015.

20.

Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency.

Zitt E, Sprenger-Mähr H, Mündle M, Lhotta K.

BMC Nephrol. 2015 Aug 4;16:128. doi: 10.1186/s12882-015-0116-3.

21.

Streptococcus uberis and Staphylococcus aureus forefoot and blood stream co-infection in a haemodialysis patient: a case report.

Valentiny C, Dirschmid H, Lhotta K.

BMC Nephrol. 2015 May 28;16:73. doi: 10.1186/s12882-015-0069-6. Review.

22.

Hafnia alvei Urosepsis in a Kidney Transplant Patient.

Stanic M, Meusburger E, Hartmann G, Lhotta K.

Case Rep Transplant. 2015;2015:863131. doi: 10.1155/2015/863131. Epub 2015 Apr 15.

23.

End-stage renal disease from renal metastases.

Ender M, Cejna M, Lhotta K.

Kidney Int. 2015 Jan;87(1):246. doi: 10.1038/ki.2014.140. No abstract available.

24.

Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case report.

Kronbichler A, Frank R, Kirschfink M, Szilágyi Á, Csuka D, Prohászka Z, Schratzberger P, Lhotta K, Mayer G.

Medicine (Baltimore). 2014 Nov;93(26):e143. doi: 10.1097/MD.0000000000000143.

25.

Iron supplementation and mortality in incident dialysis patients: an observational study.

Zitt E, Sturm G, Kronenberg F, Neyer U, Knoll F, Lhotta K, Weiss G.

PLoS One. 2014 Dec 2;9(12):e114144. doi: 10.1371/journal.pone.0114144. eCollection 2014.

26.

Variable mechanisms of vascular calcification in different segments of the arterial tree in patients with chronic kidney disease.

Zitt E, Knoll F, Lhotta K.

Kidney Int. 2014 Oct;86(4):858. doi: 10.1038/ki.2014.183. No abstract available.

27.

The serum uromodulin level is associated with kidney function.

Risch L, Lhotta K, Meier D, Medina-Escobar P, Nydegger UE, Risch M.

Clin Chem Lab Med. 2014 Dec;52(12):1755-61. doi: 10.1515/cclm-2014-0505.

PMID:
24933630
28.

Interleukin-19 as a translational indicator of renal injury.

Jennings P, Crean D, Aschauer L, Limonciel A, Moenks K, Kern G, Hewitt P, Lhotta K, Lukas A, Wilmes A, Leonard MO.

Arch Toxicol. 2015 Jan;89(1):101-6. doi: 10.1007/s00204-014-1237-3. Epub 2014 Apr 9.

PMID:
24714768
29.

Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation.

Meusburger E, Mündlein A, Zitt E, Obermayer-Pietsch B, Kotzot D, Lhotta K.

Clin Kidney J. 2013 Apr;6(2):211-215. Epub 2013 Mar 3. Erratum in: Clin Kidney J. 2013 Aug;6(4):453.

30.

Body mass index and metabolic factors predict glomerular filtration rate and albuminuria over 20 years in a high-risk population.

Nagel G, Zitt E, Peter R, Pompella A, Concin H, Lhotta K.

BMC Nephrol. 2013 Aug 20;14:177. doi: 10.1186/1471-2369-14-177.

31.

Erratum: Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation.

Meusburger E, Mündlein A, Zitt E, Obermayer-Pietsch B, Kotzot D, Lhotta K.

Clin Kidney J. 2013 Aug;6(4):453. doi: 10.1093/ckj/sft091.

32.

Treatment with oral active vitamin D is associated with decreased risk of peritonitis and improved survival in patients on peritoneal dialysis.

Kerschbaum J, Vychytil A, Lhotta K, Prischl FC, Wiesholzer M, Machhold-Fabrizii V, Kopriva-Altfahrt G, Schwarz C, Balcke P, Oberbauer R, Kramar R, König P, Rudnicki M.

PLoS One. 2013 Jul 2;8(7):e67836. doi: 10.1371/journal.pone.0067836. Print 2013.

33.

Association between genotype and phenotype in uromodulin-associated kidney disease.

Moskowitz JL, Piret SE, Lhotta K, Kitzler TM, Tashman AP, Velez E, Thakker RV, Kotanko P.

Clin J Am Soc Nephrol. 2013 Aug;8(8):1349-57. doi: 10.2215/CJN.11151012. Epub 2013 May 30.

34.

[Significance of predialysis preparation and patient information in choosing the dialysis method].

Lhotta K.

Wien Med Wochenschr. 2013 Jun;163(11-12):266-70. doi: 10.1007/s10354-013-0192-6. Epub 2013 Apr 19. Review. German.

PMID:
23604627
35.

Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients.

Zitt E, König M, Vychytil A, Auinger M, Wallner M, Lingenhel G, Schilcher G, Rudnicki M, Salmhofer H, Lhotta K.

Nephrol Dial Transplant. 2013 May;28(5):1232-40. doi: 10.1093/ndt/gfs548. Epub 2013 Jan 4.

PMID:
23291368
36.

Juvenile elastic arteries after 28 years of renal replacement therapy in a patient with complete complement C4 deficiency.

Knoll F, Zitt E, Intemann D, Lhotta K.

BMC Nephrol. 2012 Dec 2;13:161. doi: 10.1186/1471-2369-13-161.

37.

Epidemiology of uromodulin-associated kidney disease - results from a nation-wide survey.

Lhotta K, Piret SE, Kramar R, Thakker RV, Sunder-Plassmann G, Kotanko P.

Nephron Extra. 2012 Jan;2(1):147-58. doi: 10.1159/000339102. Epub 2012 Jun 1.

38.

Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease.

Zitt E, Sprenger-Mähr H, Knoll F, Neyer U, Lhotta K.

Vaccine. 2012 Jan 20;30(5):931-5. doi: 10.1016/j.vaccine.2011.11.086. Epub 2011 Dec 4.

PMID:
22142584
39.

Age-related penetrance of hereditary atypical hemolytic uremic syndrome.

Sullivan M, Rybicki LA, Winter A, Hoffmann MM, Reiermann S, Linke H, Arbeiter K, Patzer L, Budde K, Hoppe B, Zeier M, Lhotta K, Bock A, Wiech T, Gaspert A, Fehr T, Woznowski M, Berisha G, Malinoc A, Goek ON, Eng C, Neumann HP.

Ann Hum Genet. 2011 Nov;75(6):639-47. doi: 10.1111/j.1469-1809.2011.00671.x. Epub 2011 Sep 12.

40.

Interaction of time-varying albumin and phosphorus on mortality in incident dialysis patients.

Zitt E, Lamina C, Sturm G, Knoll F, Lins F, Freistätter O, Kronenberg F, Lhotta K, Neyer U.

Clin J Am Soc Nephrol. 2011 Nov;6(11):2650-6. doi: 10.2215/CJN.03780411. Epub 2011 Sep 8.

41.

Effect of cinacalcet on renal electrolyte handling and systemic arterial blood pressure in kidney transplant patients with persistent hyperparathyroidism.

Zitt E, Woess E, Mayer G, Lhotta K.

Transplantation. 2011 Oct 27;92(8):883-9. doi: 10.1097/TP.0b013e31822d87e8.

PMID:
21876476
42.

Coumarins and survival in incident dialysis patients.

Knoll F, Sturm G, Lamina C, Zitt E, Lins F, Freistätter O, Kronenberg F, Lhotta K, Neyer U.

Nephrol Dial Transplant. 2012 Jan;27(1):332-7. doi: 10.1093/ndt/gfr341. Epub 2011 Jul 18.

PMID:
21771750
43.

Association of HbA1c values with mortality and cardiovascular events in diabetic dialysis patients. The INVOR study and review of the literature.

Sturm G, Lamina C, Zitt E, Lhotta K, Haider F, Neyer U, Kronenberg F.

PLoS One. 2011;6(5):e20093. doi: 10.1371/journal.pone.0020093. Epub 2011 May 18. Review.

44.

Recurrent exit-site infection due to Staphylococcus lugdunensis--a virulent coagulase-negative Staphylococcus.

Koch LD, Knoll F, Hartmann G, Lhotta K.

Perit Dial Int. 2011 May-Jun;31(3):372-3. doi: 10.3747/pdi.2010.00272. No abstract available.

PMID:
21555429
45.

Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury.

Schwaeble WJ, Lynch NJ, Clark JE, Marber M, Samani NJ, Ali YM, Dudler T, Parent B, Lhotta K, Wallis R, Farrar CA, Sacks S, Lee H, Zhang M, Iwaki D, Takahashi M, Fujita T, Tedford CE, Stover CM.

Proc Natl Acad Sci U S A. 2011 May 3;108(18):7523-8. doi: 10.1073/pnas.1101748108. Epub 2011 Apr 18.

46.

The association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohort.

Gouya G, Sturm G, Lamina C, Zitt E, Freistätter O, Struck J, Wolzt M, Knoll F, Lins F, Lhotta K, Neyer U, Kronenberg F.

PLoS One. 2011 Mar 7;6(3):e17803. doi: 10.1371/journal.pone.0017803.

47.

Early detection of renal damage caused by fumaric acid ester therapy by determination of urinary β2-microglobulin.

Häring N, Mähr HS, Mündle M, Strohal R, Lhotta K.

Br J Dermatol. 2011 Mar;164(3):648-51. doi: 10.1111/j.1365-2133.2010.10171.x. Epub 2011 Feb 3.

PMID:
21143462
48.

Genome-wide study of familial juvenile hyperuricaemic (gouty) nephropathy (FJHN) indicates a new locus, FJHN3, linked to chromosome 2p22.1-p21.

Piret SE, Danoy P, Dahan K, Reed AA, Pryce K, Wong W, Torres RJ, Puig JG, Müller T, Kotanko P, Lhotta K, Devuyst O, Brown MA, Thakker RV.

Hum Genet. 2011 Jan;129(1):51-8. doi: 10.1007/s00439-010-0897-1. Epub 2010 Oct 26.

PMID:
20976470
49.

Uromodulin and chronic kidney disease.

Lhotta K.

Kidney Blood Press Res. 2010;33(5):393-8. doi: 10.1159/000320681. Epub 2010 Oct 14. Review.

50.

Renal resistance index-think of more than just the kidney.

Rein P, Wöss E, Lhotta K.

NDT Plus. 2010 Jun;3(3):333-334. doi: 10.1093/ndtplus/sfq057. Epub 2010 Apr 9. No abstract available.

Supplemental Content

Loading ...
Support Center